Pluri (NASDAQ:PLUR) Releases Quarterly Earnings Results

Pluri (NASDAQ:PLUR) announced its quarterly earnings results on Tuesday. The company reported ($0.94) earnings per share (EPS) for the quarter, Zacks reports. Pluri had a negative return on equity of 2,778.13% and a negative net margin of 3,551.49%.

Pluri Trading Down 0.4%

Shares of Pluri stock opened at $5.35 on Wednesday. The company has a market capitalization of $41.58 million, a P/E ratio of -0.96 and a beta of 0.77. The company has a current ratio of 5.04, a quick ratio of 5.04 and a debt-to-equity ratio of 4.44. The stock has a fifty day simple moving average of $4.55 and a 200 day simple moving average of $4.63. Pluri has a 12-month low of $3.33 and a 12-month high of $7.13.

Pluri Company Profile

Pluri Inc, a biotechnology company, engages in the development of placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions. It operates in the field of regenerative medicine, food-tech, and biologics and focuses on establishing partnerships that leverage its 3D cell-based technology to additional industries that require mass cell production.